Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (351-360 of 1,112) with videos related to

Pageof 112
Sort By:
Circulation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.
JACC. Cardiovascular Interventions|April 25, 2020
No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded TrialsMarc S Sabatine, William R Hiatt, Shinya Goto, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 1, 2010
Cardiovascular risk profiles and outcomes of Chinese living inside and outside ChinaJohn F Chiu, Alan D Bell, Robert J Herman, et al.
European Heart Journal. Acute Cardiovascular Care|June 21, 2017
Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trialTomasz Rakowski, Dariusz Dudek, Arnoud van 't Hof, et al.
Diabetes Care|December 3, 2017
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic DiseaseBrian A Bergmark, Deepak L Bhatt, Eugene Braunwald, et al.
Journal of the American College of Cardiology|August 24, 2019
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smokingMichael Miller, Deepak L Bhatt, Ph Gabriel Steg, et al.
Clinical Cardiology|February 22, 2019
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention studyDeepak L Bhatt, Kim Fox, Robert A Harrington, et al.
Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.
Pageof 112

Showing results (351-360 of 1,112) with videos related to

Sort By:
Pageof 112
Circulation|July 9, 2015
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryMatthew A Cavender, Ph Gabriel Steg, Sidney C Smith, et al.
JACC. Cardiovascular Interventions|April 25, 2020
No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded TrialsMarc S Sabatine, William R Hiatt, Shinya Goto, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 1, 2010
Cardiovascular risk profiles and outcomes of Chinese living inside and outside ChinaJohn F Chiu, Alan D Bell, Robert J Herman, et al.
European Heart Journal. Acute Cardiovascular Care|June 21, 2017
Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trialTomasz Rakowski, Dariusz Dudek, Arnoud van 't Hof, et al.
Diabetes Care|December 3, 2017
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic DiseaseBrian A Bergmark, Deepak L Bhatt, Eugene Braunwald, et al.
Journal of the American College of Cardiology|August 24, 2019
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smokingMichael Miller, Deepak L Bhatt, Ph Gabriel Steg, et al.
Clinical Cardiology|February 22, 2019
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention studyDeepak L Bhatt, Kim Fox, Robert A Harrington, et al.
Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.
Pageof 112